Phase 2 Cisplatin Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity
Solid TumorsCisplatin Nephrotoxicity
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran46 enrolled1 locationNCT07018622
Recruiting
Phase 2
Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial
Sensorineural Hearing LossOtotoxicityOtotoxicity, Drug-Induced+1 more
Siriraj Hospital40 enrolled1 locationNCT07364747
Recruiting
Phase 2
ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin
Cisplatin-induced Hearing Loss
Acousia Therapeutics GmbH40 enrolled10 locationsNCT06521190
Not Yet Recruiting
Phase 2
Phase 1b trial to investigate the prevention of hearing loss in cancer patients receiving cisplatin chemotherapy
Hearing loss (ototoxicity from cisplatin medication)
Decibel Therapeutics Australia Pty Ltd70 enrolled5 locationsACTRN12620000182998